Common Contracts
12 similar Underwriting Agreement contracts by Telestone Technologies Corp, Movano Inc., Myomo Inc, others
4,235,304 Shares MOVANO INC. COMMON STOCK PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENT November 14, 2023Underwriting Agreement • November 15th, 2023 • Movano Inc. • Electromedical & electrotherapeutic apparatus • New York
Movano Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”), for whom The Benchmark Company, LLC (the “Representative”) is acting as Representative, an aggregate of 4,235,304 shares of common stock, par value $0.0001 per share (“Common Stock”), of the Company (the “Firm Shares”) and, at the election of the Representative, up to 635,296 additional shares (the “Additional Shares”) of Common Stock (the Firm Shares and the Additional Shares being collectively called, the “Shares”).
8,000,000 Shares MOVANO INC. COMMON STOCK PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENT June 13, 2023Underwriting Agreement • June 13th, 2023 • Movano Inc. • Electromedical & electrotherapeutic apparatus • New York
Movano Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”), for whom The Benchmark Company, LLC (the “Representative”) is acting as Representative, an aggregate of 8,000,000 shares of common stock, par value $0.0001 per share (“Common Stock”), of the Company (the “Firm Shares”) and, at the election of the Representative, up to 1,200,000 additional shares (the “Additional Shares”) of Common Stock (the Firm Shares and the Additional Shares being collectively called the “Shares”).
NOCERA, INC. UNDERWRITING AGREEMENT 1,880,000 Firm UnitsUnderwriting Agreement • August 16th, 2022 • Nocera, Inc. • Agricultural prod-livestock & animal specialties • New York
Nocera, Inc., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom Spartan Capital Securities, LLC (“Spartan Capital”) and Revere Securities LLC are acting as joint representatives (the “Representatives”), an aggregate of 1,880,000 units (the “Firm Units”), with each unit consisting of one share of common stock, par value $0.001 per share (the “Common Stock”) of the Company (the “Firm Shares”), and a warrant to purchase two shares of Common Stock, at an exercise price of $3.85 per share and with a term of five (5) years (the “Firm Warrants”). The Company also proposes to sell to the Underwriters, upon the terms and conditions set forth in Section 4 hereof, in the aggregate, up to 282,000 additional shares of Common Stock representing 15% of the Firm Shares sold in the offering from the Company (the “Option Shares”) and/
FATHOM HOLDINGS INC. UNDERWRITING AGREEMENT [●] Shares of Common StockUnderwriting Agreement • July 16th, 2020 • Fathom Holdings Inc. • Real estate agents & managers (for others) • New York
Fathom Holdings Inc., a North Carolina corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to Roth Capital Partners, LLC (the “Underwriter”) [●] authorized but unissued shares (the “Firm Shares”) of common stock of the Company, no par value (the “Common Stock”). In addition, the Company and Glenn Sampson, its only selling shareholder (the “Selling Shareholder”), also propose to sell to the Underwriter, upon the terms and conditions set forth in Section 4 hereof, up to an additional (i) [●] authorized but unissued shares of Common Stock (the “Company Option Shares”) and (ii) [●] issued and outstanding shares held by the Selling Stockholder (the “Secondary Shares” and, together with the Company Option Shares, the “Option Shares”). The Firm Shares, the Secondary Shares and the Company Option Shares are hereinafter collectively referred to as the “Shares”. The Shares, the Underwriter Warrants (as defined below) and the Underwriter War
MYOMO, INC. UNDERWRITING AGREEMENT 1,660,000 Shares of Common Stock Common Warrants to Purchase up to 2,143,000 Shares of Common Stock Pre-Funded Warrants to Purchase up to 483,000 Shares of Common StockUnderwriting Agreement • February 12th, 2020 • Myomo Inc • Orthopedic, prosthetic & surgical appliances & supplies • New York
Myomo, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom Roth Capital Partners, LLC is acting as the representative (the “Representative”), (i) an aggregate of 1,660,000 authorized but unissued shares (the “Firm Shares”) of common stock, par value $0.0001 per share of the Company (the “Common Stock”), (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to an aggregate of 483,000 shares of Common Stock at an exercise price of $0.0001 per share (the “Pre-Funded Warrant Shares”) and (iii) warrants (the “Firm Warrants”) to purchase up to an aggregate of 2,143,000 shares of Common Stock (the “Firm Warrant Shares”). The Firm Shares, the Firm Pre-Funded Warrants, the Firm Warrants, the Firm Pre-Funded Warrant Shares and the Firm Warrant Shares are collectively referred to as the “Firm Securities.” Th
MYOMO, INC. UNDERWRITING AGREEMENT [ ] Shares of Common Stock Common Warrants to Purchase up to [ ] Shares of Common Stock Pre-Funded Warrants to Purchase up to [ ] Shares of Common StockUnderwriting Agreement • February 3rd, 2020 • Myomo Inc • Orthopedic, prosthetic & surgical appliances & supplies • New York
Myomo, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom Roth Capital Partners, LLC is acting as the representative (the “Representative”), (i) an aggregate of [ ] authorized but unissued shares (the “Firm Shares”) of common stock, par value $0.0001 per share of the Company (the “Common Stock”), (ii) pre-funded warrants (the “Firm Pre-Funded Warrants”) to purchase up to an aggregate of [ ] shares of Common Stock at an exercise price of $0.0001 per share (the “Firm Pre-Funded Warrant Shares”) and (iii) warrants (the “Firm Warrants”) to purchase up to an aggregate of [ ] shares of Common Stock (the “Firm Warrant Shares”). The Firm Shares, the Firm Pre-Funded Warrants, the Firm Warrants, the Firm Pre-Funded Warrant Shares and the Firm Warrant Shares are collectively referred to as the “Firm Securities.” The Comp
SENESTECH, INC. 5,400,000 Shares of Common Stock Warrants to Purchase up to 4,050,000 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • November 17th, 2017 • SenesTech, Inc. • Agricultural chemicals • Delaware
SenesTech, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”) , an aggregate of 5,400,000 authorized but unissued shares (the “Firm Shares”) of common stock, par value $0.001 per share (the “Common Stock”), of the Company and (ii) warrants (the “Firm Warrants”) to purchase up to an aggregate of 4,050,000 shares of Common Stock (the “Firm Warrant Shares”). The Company also proposes to sell to the Underwriters, upon the terms and conditions set forth in Section 4 hereof, up to an additional (i) 810,000 shares of Common Stock (the “Option Shares”) and warrants (the “Option Warrants”) to purchase up to an aggregate of 607,500 shares of Common Stock (the “Option Warrant Shares” and together with the Firm Warrant Shares, the “Warrant Shares”). The Firm Shares and the Option Shares are hereinafter collectively referred to as t
SENESTECH, INC. [*] Shares of Common Stock Warrants to Purchase up to [*] Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • November 8th, 2017 • SenesTech, Inc. • Agricultural chemicals • Delaware
SenesTech, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”) , an aggregate of [*] authorized but unissued shares (the “Firm Shares”) of common stock, par value $0.001 per share (the “Common Stock”), of the Company and (ii) warrants (the “Firm Warrants”) to purchase up to an aggregate of [*] shares of Common Stock (the “Firm Warrant Shares”). The Company also proposes to sell to the Underwriters, upon the terms and conditions set forth in Section 4 hereof, up to an additional (i) [*] shares of Common Stock (the “Option Shares”) and warrants (the “Option Warrants”) to purchase up to an aggregate of [*] shares of Common Stock (the “Option Warrant Shares” and together with the Firm Warrant Shares, the “Warrant Shares”). The Firm Shares and the Option Shares are hereinafter collectively referred to as the “Shares” and the
1,675,000 Shares Telestone Technologies Corporation Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • November 30th, 2010 • Telestone Technologies Corp • Communications equipment, nec • New York
Telestone Technologies Corporation, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule A hereto (each, an “Underwriter” and collectively, the “Underwriters”) for whom Roth Capital Partners LLC (the “Representative”) is acting as the representative an aggregate of 1,675,000 authorized but unissued shares (the “Underwritten Shares”) of Common Stock, par value $0.001 per share (the “Common Stock”), of the Company. The Company has granted the Representative, on behalf of the Underwriters, the option to purchase an aggregate of up to 251,250 additional shares of Common Stock (the “Additional Shares”) as may be necessary to cover over-allotments made in connection with the offering. The Underwritten Shares and Additional Shares are collectively referred to as the “Shares.”
1,675,000 Shares Telestone Technologies Corporation Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • November 29th, 2010 • Telestone Technologies Corp • Communications equipment, nec • New York
1,675,000 Shares Telestone Technologies Corporation Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • November 24th, 2010 • Telestone Technologies Corp • Communications equipment, nec • New York
2,857,143 Shares UNIVERSAL TRAVEL GROUP Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • June 16th, 2010 • Universal Travel Group • Transportation services • New York
Universal Travel Group, a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to Brean Murray, Carret & Co, LLC (“Brean” or the “Representative”) as representative of the underwriters listed on Schedule IV hereto, (collectively, the Underwriters”) an aggregate of 2,857,143 authorized but unissued shares (the “Underwritten Shares”) of Common Stock, par value $0.001 per share (the “Common Stock”), of the Company. The Company has granted the Representative the option to purchase an aggregate of up to 428,572 additional shares of Common Stock (the “Additional Shares”) as may be necessary to cover over-allotments made in connection with the offering. The Underwritten Shares and Additional Shares are collectively referred to as the “Shares.”
